— Know what they know.
Not Investment Advice

CNTX NASDAQ

Context Therapeutics Inc.
1W: -10.4% 1M: -14.6% 3M: -51.4% YTD: -80.0% 1Y: -68.1% 3Y: -76.0%
$0.31
-0.00 (-1.49%)
 
Weekly Expected Move ±8.1%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 28 · $28.5M mcap · 65M float · 3.63% daily turnover · Short 47% of daily vol

Balance Sheet Trends

Total Assets
$68M -30.2% ▼
5Y CAGR: +171.1%
Total Liabilities
$8M +180.4% ▲
5Y CAGR: -14.3%
Shareholders Equity
$60M -36.5% ▼
Cash & Investments
$66M -30.1% ▼
5Y CAGR: +186.6%
Total Debt
$112K -48.9% ▼
5Y CAGR: -54.8%
Net Debt
-$66M +30.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$50M$35M$14M$94M$66M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$50M$35M$14M$94M$66M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$2M$2M$3M$2M
Total Current Assets$51M$38M$16M$98M$68M
Property, Plant & Equip.$0$80K$16K$231K$140K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$50K$0$0$0$0
Other Non-Current Assets$0$33K$0$0$0
Total Non-Current Assets$50K$112K$16K$231K$140K
Total Assets$51M$38M$16M$98M$68M
— Liabilities —
Accounts Payable$2M$936K$2M$1M$3M
Short-Term Debt$0$0$0$0$112K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$86K$854K$661K$942K$5M
Total Current Liabilities$3M$3M$4M$3M$8M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$112K$0
Total Liabilities$3M$3M$4M$3M$8M
— Equity —
Common Stock$16K$16K$16K$90K$92K
Retained Earnings-$29M-$44M-$68M-$95M-$131M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$48M$35M$12M$95M$60M
Total Liabilities & Equity$51M$38M$16M$98M$68M
— Key Metrics —
Total Debt$0$55K$0$219K$112K
Net Debt-$50M-$35M-$14M-$94M-$66M
Total Investments$50K$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms